The Mexico biologics market is expanding rapidly, driven by advancements in biotechnology, growing investments in healthcare, and increasing prevalence of chronic diseases. Rising demand for targeted therapies and biosimilars, along with supportive government initiatives, is significantly propelling market growth and improving healthcare outcomes across the nation. https://www.imarcgroup.com/mexico-biologics-market